We are live on ! Find out more
CPXX

CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX

Delisted

CPXX was delisted on the 11th of July, 2016.

Back to rankings

14 hedge funds and large institutions have $5.34M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

8% more funds holding

Funds holding: 13 → 14 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

31% less capital invested

Capital invested by funds: $7.69M → $5.34M (-$2.35M)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
6
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$68.7K
2
SIM
Spark Investment Management
New York
+$44.8K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$43.9K
4
TRCT
Tower Research Capital (TRC)
New York
+$7.02K
5
Deutsche Bank
Deutsche Bank
Germany
+$4.77K

Top Sellers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
-$1.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Caxton Corporation
New Jersey
$4.4M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$481K +$43.9K +21,176 +9%
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$253K – – –
SIM
4
Spark Investment Management
New York
$80K +$44.8K +21,600 +109%
ACI
5
Alpha Cubed Investments
California
$63K – – –
CPA
6
Cowen Prime Advisors
New York
$38K – – –
TRCT
7
Tower Research Capital (TRC)
New York
$7K +$7.02K +3,385 New
BIM
8
BlackRock Investment Management
Delaware
$6K +$919 +443 +15%
Deutsche Bank
9
Deutsche Bank
Germany
$4K +$4.77K +2,300 New
Bank of America
10
Bank of America
North Carolina
$3K – – –
MA
11
MUFG Americas
New York
$3K +$1.14K +550 +56%
NPC
12
National Planning Corporation
California
$2.14K +$2.07K +1,000 New
SM
13
Sabby Management
Florida
$275 +$68.7K +33,105 +31%
OM
14
Opaleye Management
Massachusetts
– -$1.02M -405,000 Closed
Morgan Stanley
15
Morgan Stanley
New York
– +$27 +13 +30%

CPXX Hedge Fund Activity: Q4 2014 in Review

14 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q4 2014, worth a combined $5.34M — down 31% from $7.69M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPXX positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $68.7K. The largest seller was Opaleye Management, exiting entirely with an estimated $1.02M sold.

  • 14 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q4 2014, up from 13 in Q3 2014.
  • Funds reported $5.34M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q4 2014, down 31% quarter-over-quarter.
  • 3 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q4 2014 and 1 closed out, a net change of +2 holders.
  • The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q4 2014 was Sabby Management, an estimated $68.7K added.
  • The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q4 2014 was Opaleye Management, an estimated $1.02M sold.

Based on aggregated 13F filings for Q4 2014.